Phase I clinical trial of the anti-EGFR monoclonal antibody nimotuzumab with concurrent external thoracic radiotherapy in Canadian patients diagnosed with stage IIb, III or IV non-small cell lung cancer unsuitable for radical therapy

Author： Bebb Gwyn   Smith Colum   Rorke Stewart   Boland William   Nicacio Leonardo   Sukhoo Ryan   Brade Anthony  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.67, Iss.4, 2011-04, pp. : 837-845

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Phase I Clinical Trial of Concurrent Paclitaxel, Carboplatin, and External Beam Chest Irradiation with Glutamine in Patients with Locally Advanced Non-Small Cell Lung Cancer

By Jazieh Abdul Rahman   Younas Ahmer   Safa Malek   Redmond Kevin   Buncher Ralph   Howington John  

Cancer Investigation, Vol. 25, Iss. 5, 2007-07 ,pp. : 294-298

Informa Healthcare

Access to resources Recommend Favorite

Phase I/II study of concurrent twice-weekly paclitaxel and weekly cisplatin with radiation therapy for stage III non-small cell lung cancer

By Solomon B.   Ball D.L.   Richardson G.   Smith J.G.   Millward M.   MacManus M.   Michael M.   Wirth A.   O'Kane C.   Muceniekas L.   Ryan G.   Rischin D.  

Lung Cancer, Vol. 41, Iss. 3, 2003-09 ,pp. : 353-361

Elsevier

Access to resources Recommend Favorite

Weekly docetaxel and concomitant boost radiotherapy for non-small cell lung cancer. A phase I/II dose escalation trial

By Koukourakis M.I.   Kourousis C.   Kamilaki M.   Koukouraki S.   Giatromanolaki A.   Kakolyris S.   Kotsakis A.   Androulakis N.   Bahlitzanakis N.   Georgoulias V.  

European Journal of Cancer, Vol. 34, Iss. 6, 1998-05 ,pp. : 838-844

Elsevier

Access to resources Recommend Favorite

Phase II Trial of Docetaxel in Asian Patients with Inoperable Stage III Non-Small Cell Lung Cancer

By Goh Boon C.   Lehnert Manfred   Lim Hong L.   Ng Alan W. K.   Chan Choong C.   Kong Hwai L.   Lee Soo C.   Wee Joseph   Chua E. T.   Wong John E. L.  

Acta Oncologica, Vol. 39, Iss. 2, 2000-08 ,pp. : 225-229

Informa Healthcare

Access to resources Recommend Favorite

Treatment of non-small cell lung cancer patients with the trifunctional monoclonal antibody catumaxomab (anti-EpCAM × anti-CD3): a phase I study

By Sebastian Martin   Passlick Bernward   Friccius-Quecke Hilke   Jäger Michael   Lindhofer Horst   Kanniess Frank   Wiewrodt Rainer   Thiel Eckhard   Buhl Roland   Schmittel Alexander  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 10, 2007-10 ,pp. : 1637-1644

Springer Publishing Company

Access to resources Recommend Favorite